Dasher Neuroscience

Dasher Neuroscience is a biotechnology company founded by PureTech Health that focuses on developing novel therapies for neurological diseases. The company leverages insights into the glymphatic system, the brain's waste clearance mechanism, to address neurodegenerative conditions. By enhancing the clearance of toxic proteins and metabolic waste, Dasher aims to provide transformative treatments for disorders such as Alzheimer's disease and other dementias. The company is currently in the pre-clinical stage of development and operates as part of PureTech's internal pipeline of founded entities. Its approach represents a shift toward systemic management of brain health through the modulation of fluid dynamics and waste transport.